Abstract
These days, science is not what it used to be. Most academic senior scientists spend much of their time in a continuous quest for money to pay for their research and their staff, hence their understandable frustration when excessive red tape diverts precious time away from doing ‘real science’. Equally frustrating are the so‐called ‘priorities for research’ when scientists find that their pet organism or favourite physiological pathway is not classified as ‘priority’. Furthermore, many of them deplore the current emphasis on ‘applied research’—whatever that is—and the focus on large infrastructures and platform technologies that, in their view, are now all the rage among European policy makers. Against this backdrop, the Framework Programmes (FP) of the European Commission (EC) have attracted their share of criticism and sarcasm from disgruntled scientists all over Europe, which is also reflected in the chaotic and sometimes hostile relationship between the EC and the scientific community. Now that FP6 is about to be implemented, it would be useful to take a closer look at the EC's science policy vision for Europe and to reassess the partnership between the scientific community and the Commission. ![][1] Last year, the European Life Sciences Forum (ELSF) asked its membership to respond to the EC's consultation ‘Towards a Strategic Vision of Life Sciences and Biotechnology’. Among the very few contributions we received, one was indicative of a widely‐held view within the scientific community: ‘There has been something seriously wrong with the type and mechanism of EC research funding for a number of years, and this promises to deteriorate further in FP6. Many individuals and organisations […] have tried to communicate both the various problems and potential solutions to the Commission, but to little effect. The response, if there is one, is to deflect criticism, usually by some woolly statement about the … [1]: pending:yes